Back to Search
Start Over
Valeant Pharmac
- Source :
- The Value Line Investment Survey (Part 3 - Ratings & Reports). April 18, 2008, Vol. 63 Issue 34, p1289, 1 p.
- Publication Year :
- 2008
-
Abstract
- The shares of Valeant Pharmaceuticals have trended downward over the years and their pipeline products are not likely to change the company's prospects. The Costa Mesa-based company manufactures anti-infectives, dermatologicals, vitamins, and vision care products.
Details
- Language :
- English
- ISSN :
- 00422401
- Volume :
- 63
- Issue :
- 34
- Database :
- Gale General OneFile
- Journal :
- The Value Line Investment Survey (Part 3 - Ratings & Reports)
- Publication Type :
- Periodical
- Accession number :
- edsgcl.178436744